Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia.

Chaorattanakawee S, Lon C, Chann S, Thay KH, Kong N, You Y, Sundrakes S, Thamnurak C, Chattrakarn S, Praditpol C, Yingyuen K, Wojnarski M, Huy R, Spring MD, Walsh DS, Patel JC, Lin J, Juliano JJ, Lanteri CA, Saunders DL.

Malar J. 2017 Sep 30;16(1):392. doi: 10.1186/s12936-017-2034-2.

2.

Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow.

Htun MW, Mon NCN, Aye KM, Hlaing CM, Kyaw MP, Handayuni I, Trimarsanto H, Bustos D, Ringwald P, Price RN, Auburn S, Thriemer K.

Malar J. 2017 Jul 10;16(1):281. doi: 10.1186/s12936-017-1912-y.

3.

MOLECULAR SURVEILLANCE OF Plasmodium vivax AND Plasmodium falciparum DHFR MUTATIONS IN ISOLATES FROM SOUTHERN IRAN.

Sharifi-Sarasiabi K, Haghighi A, Kazemi B, Taghipour N, Mojarad EN, Gachkar L.

Rev Inst Med Trop Sao Paulo. 2016;58:16. doi: 10.1590/S1678-9946201658016. Epub 2016 Mar 22.

4.

Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border.

Höglund R, Moussavi Y, Ruengweerayut R, Cheomung A, Äbelö A, Na-Bangchang K.

Malar J. 2016 Feb 29;15:129. doi: 10.1186/s12936-016-1181-1.

5.

Malaria ecology along the Thailand-Myanmar border.

Parker DM, Carrara VI, Pukrittayakamee S, McGready R, Nosten FH.

Malar J. 2015 Oct 5;14:388. doi: 10.1186/s12936-015-0921-y.

6.

Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam.

Thanh PV, Hong NV, Van NV, Louisa M, Baird K, Xa NX, Peeters Grietens K, Hung le X, Duong TT, Rosanas-Urgell A, Speybroeck N, D'Alessandro U, Erhart A.

Antimicrob Agents Chemother. 2015 Dec;59(12):7411-9. doi: 10.1128/AAC.00791-15. Epub 2015 Sep 21.

7.

Evaluation of single nucleotide polymorphisms of pvmdr1 and microsatellite genotype in Plasmodium vivax isolates from Republic of Korea military personnel.

Chung DI, Jeong S, Dinzouna-Boutamba SD, Yang HW, Yeo SG, Hong Y, Goo YK.

Malar J. 2015 Sep 4;14:336. doi: 10.1186/s12936-015-0845-6.

8.

Plasmodium vivax drug resistance genes; Pvmdr1 and Pvcrt-o polymorphisms in relation to chloroquine sensitivity from a malaria endemic area of Thailand.

Rungsihirunrat K, Muhamad P, Chaijaroenkul W, Kuesap J, Na-Bangchang K.

Korean J Parasitol. 2015 Feb;53(1):43-9. doi: 10.3347/kjp.2015.53.1.43. Epub 2015 Feb 27.

9.

Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.

Yuan L, Wang Y, Parker DM, Gupta B, Yang Z, Liu H, Fan Q, Cao Y, Xiao Y, Lee MC, Zhou G, Yan G, Baird JK, Cui L.

Antimicrob Agents Chemother. 2015 Feb;59(2):1230-5. doi: 10.1128/AAC.04270-14. Epub 2014 Dec 15.

10.

Monitoring Plasmodium vivax chloroquine sensitivity along China-Myanmar border of Yunnan Province, China during 2008-2013.

Liu H, Yang HL, Tang LH, Li XL, Huang F, Wang JZ, Li CF, Wang HY, Nie RH, Guo XR, Lin YX, Li M, Xu JW.

Malar J. 2014 Sep 15;13:364. doi: 10.1186/1475-2875-13-364.

11.

Phenotyping clinical resistance to chloroquine in Plasmodium vivax in northeastern Papua, Indonesia.

Asih PB, Syafruddin D, Leake J, Sorontou Y, Sadikin M, Sauerwein RW, Vinetz J, Baird JK.

Int J Parasitol Drugs Drug Resist. 2011 Oct 5;1(1):28-32. doi: 10.1016/j.ijpddr.2011.08.001. eCollection 2011 Dec.

12.

Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studies.

Naing C, Racloz V, Whittaker MA, Aung K, Reid SA, Mak JW, Tanner M.

PLoS One. 2013 Dec 3;8(12):e78819. doi: 10.1371/journal.pone.0078819. eCollection 2013. Review.

13.
14.

Border malaria associated with multidrug resistance on Thailand-Myanmar and Thailand-Cambodia borders: transmission dynamic, vulnerability, and surveillance.

Bhumiratana A, Intarapuk A, Sorosjinda-Nunthawarasilp P, Maneekan P, Koyadun S.

Biomed Res Int. 2013;2013:363417. doi: 10.1155/2013/363417. Epub 2013 Jun 25. Review.

15.

Longitudinal in vitro surveillance of Plasmodium falciparum sensitivity to common anti-malarials in Thailand between 1994 and 2010.

Parker D, Lerdprom R, Srisatjarak W, Yan G, Sattabongkot J, Wood J, Sirichaisinthop J, Cui L.

Malar J. 2012 Aug 21;11:290. doi: 10.1186/1475-2875-11-290.

16.

Functional analysis of Plasmodium vivax dihydrofolate reductase-thymidylate synthase genes through stable transformation of Plasmodium falciparum.

Auliff AM, Balu B, Chen N, O'Neil MT, Cheng Q, Adams JH.

PLoS One. 2012;7(7):e40416. doi: 10.1371/journal.pone.0040416. Epub 2012 Jul 9.

17.

Plasmodium vivax malaria endemicity in Indonesia in 2010.

Elyazar IR, Gething PW, Patil AP, Rogayah H, Sariwati E, Palupi NW, Tarmizi SN, Kusriastuti R, Baird JK, Hay SI.

PLoS One. 2012;7(5):e37325. doi: 10.1371/journal.pone.0037325. Epub 2012 May 17.

18.

Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.

Phyo AP, Lwin KM, Price RN, Ashley EA, Russell B, Sriprawat K, Lindegardh N, Singhasivanon P, White NJ, Nosten F.

Clin Infect Dis. 2011 Nov;53(10):977-84. doi: 10.1093/cid/cir631.

19.

Challenges and prospects for malaria elimination in the Greater Mekong Subregion.

Cui L, Yan G, Sattabongkot J, Chen B, Cao Y, Fan Q, Parker D, Sirichaisinthop J, Su XZ, Yang H, Yang Z, Wang B, Zhou G.

Acta Trop. 2012 Mar;121(3):240-5. doi: 10.1016/j.actatropica.2011.04.006. Epub 2011 Apr 14.

20.

High genetic polymorphism of relapsing P. vivax isolates in northwest Colombia.

Restrepo E, Imwong M, Rojas W, Carmona-Fonseca J, Maestre A.

Acta Trop. 2011 Jul;119(1):23-9. doi: 10.1016/j.actatropica.2011.03.012. Epub 2011 Apr 7.

Supplemental Content

Support Center